IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1

Eriksson E, Milenova I, Wenthe J, Moreno R, Alemany R, Loskog A

J.I. 202 (3) 787-798 [2019-02-01; online 2019-01-07]

NGI Uppsala (Uppsala Genome Center) [Service]

National Genomics Infrastructure [Service]

QC bibliography QC xrefs

DOI 10.4049/jimmunol.1800717

Crossref 10.4049/jimmunol.1800717